Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Y Morgan

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
The New England Journal of Medicine|April 7, 1977
Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathyM Y Morgan, A Jakobovits, A Elithorn, et al.
Gut|March 1, 1985
Cholestatic jaundice in the haemolytic-uraemic syndrome: a case reportG Jeffrey, C C Kibbler, R Baillod, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Letter: stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfallsH D Zacharias, C D Jackson, M Y Morgan, et al.
Advances in Alcohol & Substance Abuse|January 1, 1988
The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosisJ P Casazza, J Freitas, D Stambuk, et al.
Digestive Diseases and Sciences|October 1, 1982
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosisR W Chapman, M Y Morgan, M Laulicht, et al.
Clinical and Laboratory Haematology|January 1, 1981
Macrocytosis in alcohol-related liver disease: its value for screeningM Y Morgan, M E Camilo, W Luck, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1987
The measurement of 1,2-propanediol, D, L-2,3-butanediol and meso-2,3-butanediol in controls and alcoholic cirrhoticsJ P Casazza, J Frietas, D Stambuk, et al.
Public Health|November 10, 2021
Societal reopening after the COVID-19 pandemicS D Taylor-Robinson, M Y Morgan, P Olupot-Olupot, et al.
Gut|March 1, 1978
Serum prolactin in liver disease and its relationship to gynaecomastiaM Y Morgan, A W Jakobovits, M B Gore, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
The New England Journal of Medicine|April 7, 1977
Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathyM Y Morgan, A Jakobovits, A Elithorn, et al.
Gut|March 1, 1985
Cholestatic jaundice in the haemolytic-uraemic syndrome: a case reportG Jeffrey, C C Kibbler, R Baillod, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Letter: stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfallsH D Zacharias, C D Jackson, M Y Morgan, et al.
Advances in Alcohol & Substance Abuse|January 1, 1988
The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosisJ P Casazza, J Freitas, D Stambuk, et al.
Digestive Diseases and Sciences|October 1, 1982
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosisR W Chapman, M Y Morgan, M Laulicht, et al.
Clinical and Laboratory Haematology|January 1, 1981
Macrocytosis in alcohol-related liver disease: its value for screeningM Y Morgan, M E Camilo, W Luck, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1987
The measurement of 1,2-propanediol, D, L-2,3-butanediol and meso-2,3-butanediol in controls and alcoholic cirrhoticsJ P Casazza, J Frietas, D Stambuk, et al.
Public Health|November 10, 2021
Societal reopening after the COVID-19 pandemicS D Taylor-Robinson, M Y Morgan, P Olupot-Olupot, et al.
Gut|March 1, 1978
Serum prolactin in liver disease and its relationship to gynaecomastiaM Y Morgan, A W Jakobovits, M B Gore, et al.
Pageof 10